Home -> Law Blog Directory -> Qui Tam Blogs -> False Claims Act - Qui Tam
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Qui Tam
: False Claims Act - Qui TamWhistleblower suit charges Pfizer with off-label marketing of Lipitor
By Qui Tam
The lawsuit, filed in 2004 but just unsealed, alleges that Pfizer used misleading educational programs as part of a marketing strategy to encourage physicians to prescribe the cholesterol-lowering medication for patients who did not need it.
Companies are not allowed to promote drugs for indications that have not been approved by the Food and Drug Administration, but doctors aren't prohibited from prescribing them for unapproved uses. Independent educational programs can discuss off-label uses that aren't FDA approved. The lawsuit charges that the Pfizer-funded programs weren't independent.
Full post as published by False Claims Act - Qui Tam on December 20, 2007 (boomark / email).
Unsealed Lipitor lawsuit alleges defective marketing
--> Unsealed Lipitor lawsuit alleges defective marketing Related Pages: Lipitor Pfizer, Inc. Heart attack Defective Marketing Heart Failure Pfizer is facing a lawsuit from a former employee who alleges the company illegally bolstered sales of its top-selling drug Lipitor with a campaign of education programs that misled doctors...
Pfizer, Inc. faces lawsuit after alleged deceptive marketing
--> Pfizer, Inc. faces lawsuit after alleged deceptive marketing Former employee says company misled doctors Related Pages: Pfizer, Inc. Lipitor Defective Marketing In February 2004, a former official of drug manufacturer Pfizer Inc...
Pfizer withdraws Lipitor marketing over potential deceptive marketing investigation
--> Pfizer withdraws Lipitor marketing over potential deceptive marketing investigation Consumers may have been misled by Jarvic artificial heart promotions Related Pages: Pfizer, Inc...
Pfizer Pulls Lipitor Ads featuring DR. Jarvik
Pfizer announced it is voluntarily withdrawing Lipitor advertising and promotion featuring Dr. Robert Jarvik. For more, go here.
Pfizer, Ranbaxy settle Lipitor matter
AP reports: Pfizer Inc. and India's Ranbaxy Laboratories Ltd. said June 18 they have settled their patent dispute over the blockbuster cholesterol drug Lipitor, delaying the release of generic versions in the U...
Ranbaxy to settle with Takeda over Actos (pioglitazone)
The Business-Standard reports: The Indian drug major [Ranbaxy] , which last week announced a high-profile patent settlement deal with Pfizer on Lipitor, the world's largest selling drug, may now review its litigation with Japan's Takeda on Actos (pioglitazone)...
Mesothelioma Law Suit
Asbestos Exposure
Bextra Product Recall
Find a Bextra Lawyer
Bextra Injury Risks
Bextra Increases Risk of Fatal Heart Attack
Qui Tam Whistleblower - Government Fraud - Qui Tam Lawsuit
Qui Tam Whistleblower alleging fraud against the government reported by an individual acting as a government whistleblower.
Vytorin Marketing
alleged false claims in marketing campaign.
Lipitor
Review of Studies Show No Significant Benefit in Women
Police Whistleblower
Officer awarded $980,000 for whistleblower violations and retaliation.
AT&T International Roaming Charges, AT&T lawsuit
AT&T Faces International Roaming Charges Lawsuit
Pfizer, Pharmacia
Found Guilty of Medicaid Fraud








